MNTA Market Cap History
Below is a table of the MNTA market cap history going back to 2/26/2010:

Date MNTA Market Cap
2/26/2010656.44M
5/3/2010648.61M
7/28/20101.04B
11/1/2010722.84M
2/28/2011693.15M
5/2/2011974.84M
8/1/2011885.31M
10/31/2011758.37M
2/15/2012767.45M
5/2/2012817.62M
8/3/2012711.68M
11/2/2012658.59M
2/15/2013638.03M
5/6/2013590.91M
8/1/2013864.26M
11/4/2013866.06M
2/15/2014936.70M
4/30/2014602.34M
7/31/2014561.93M
10/31/2014578.78M
2/13/2015643.18M
4/27/20151.15B
7/31/20151.50B
10/30/20151.13B
2/1/2016870.54M
4/12/2016648.40M
7/29/2016796.58M
8/31/2016853.22M
10/31/2016791.89M
12/12/20161.03B
1/27/20171.08B
2/1/20171.39B
4/24/2017990.54M
7/26/20171.28B
10/30/20171.10B
2/9/20181.25B
5/2/20181.63B
8/3/20182.23B
11/1/20181.06B
2/11/20191.26B
4/29/20191.43B
7/31/20191.12B
10/22/20191.44B
2/13/20203.71B
4/23/20203.65B
8/3/20203.84B

Also see: MNTA Shares Outstanding History
and MNTA YTD Return
MNTA Historical Market Cap:
+18.45% CAGR
MNTA Historical Market Cap: +18.45% CAGR

Mouse over chart for data details
2/26/2010 ...8/3/2020
Momenta Pharmaceuticals is a biotechnology company focused on the discovery and development of biologic therapies for the treatment of rare immune-mediated diseases. Co.'s programs include: M281, a fully-human anti-neonatal Fc receptor, aglycosylated immunoglobulin G (IgG1), monoclonal antibody; M254, a hyper-sialylated immunoglobulin; M230, a novel recombinant trivalent human IgG1 Fc multimer; and M710, a biosimilar of EYLEA, a vascular endothelial growth factor inhibitor indicated for the treatment of Neovascular (Wet) Age-related Macular Degeneration, Macular Edema following Retinal Vein Occlusion, Diabetic Macular Edema (DME), and Diabetic Retinopathy in patients with DME. We show 46 historical shares outstanding datapoints in our MNTA shares outstanding history coverage, used to compute MNTA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MNTA market cap history over the course of time is important for investors interested in comparing MNTA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MNTA versus a peer is one thing; comparing MNTA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MNTA can fluctuate over the course of history. With this page we aim to empower investors researching MNTA by allowing them to research the MNTA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree MNTA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Momenta Pharmaceuticals (MNTA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

MODD Market Cap History
MODV Market Cap History
MOH Market Cap History
MORF Market Cap History
MOTS Market Cap History
MOVE Market Cap History
MRIC Market Cap History
MRK Market Cap History
MRKR Market Cap History
MRNA Market Cap History
More Healthcare companies »

 

MNTA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.